Skip to main content
Gujarat Ambuja Exports Ltd. logo

Gujarat Ambuja Exports Ltd. — Investor Relations & Filings

Ticker · GAEL ISIN · INE036B01030 LEI · 335800M9TVMR5FIXZ129 BSE.NS Manufacturing
Open in API
Filings indexed 964 across all filing types
Latest filing 2026-01-30 Regulatory Filings
Country IN India
Listing BSE.NS GAEL

About Gujarat Ambuja Exports Ltd.

https://www.ambujagroup.com

Gujarat Ambuja Exports Ltd. is an agro-processing organization specializing in the manufacturing of corn-based starch derivatives, soy products, and cotton yarn. The company operates integrated processing facilities to produce liquid glucose, sorbitol, maltodextrin, and dextrose monohydrate, serving the food, pharmaceutical, and paper sectors. Its soy division focuses on de-oiled cakes, refined soy oil, and lecithin for the animal feed and human nutrition markets. GAEL maintains an extensive global export footprint, providing high-volume industrial ingredients that meet international quality standards. The company leverages large-scale production capabilities to supply diverse applications in the textile and healthcare industries, emphasizing efficiency and consistency across its product portfolio.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a communication to members regarding the unaudited financial results for the quarter and nine months ended 31st December 2025. It states that the financial results have been reviewed by auditors and approved by the board, and that the results have been uploaded on the company's website. The document itself does not contain the actual financial statements or detailed financial data but serves as a notification or summary communication. The document length is 3763 characters, which is relatively short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is an announcement of the financial results rather than the full interim/quarterly report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement about the financial results being communicated to shareholders without containing the full report.
2026-01-30 English
Change in Management
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding a change in senior management personnel. It specifically discloses the cessation of a senior management person due to appointment as a Whole-time Director. The document references Regulation 30 of SEBI Listing Regulations, which governs disclosures about changes in management. The content is focused on announcing a management change rather than providing financial data, audit information, or other report types. The document length is 3934 characters, which is relatively short and consistent with a regulatory announcement. Therefore, the document fits the category of Board/Management Information (MANG).
2026-01-30 English
Change in Director(s)
Interim / Quarterly Report Classification · 85% confidence The document is a detailed Board Meeting outcome filed with BSE and NSE, including standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2025, together with the independent auditor’s review report and full financial statement schedules. It contains substantive interim financial data. Under the taxonomy, this constitutes an Interim/Quarterly Report rather than a brief earnings release or a mere announcement. 9M 2026
2026-01-30 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 93% confidence The document is an outcome of a board meeting where the Board approved the standalone and consolidated unaudited financial results for the quarter and nine months ended 31 December 2025, accompanied by the auditor’s review report and full financial statements. This is more than a headline earnings release and contains complete interim financial data, consistent with an Interim/Quarterly Report. Hence, the appropriate category is IR (Interim / Quarterly Report). 9M 2026
2026-01-30 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-23 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about an upcoming Board Meeting scheduled to consider and approve unaudited financial results for the third quarter and nine months ended 31st December 2025. It is an intimation under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The document does not contain the financial results themselves but announces the date of the meeting where these results will be approved. The document length is short (2316 characters) and serves as a notice rather than a report. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER) but a Regulatory Filing (RNS) as it is a general regulatory announcement about a board meeting and upcoming financial results approval.
2026-01-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.